Immunic reported $-23.33M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
BioMarin Pharmaceutical USD 105.6M 24.04M Jun/2026
Cipla INR 8.88B 2.74B Jun/2026
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -9.02M 65.06M Mar/2026
CSL USD 2.64B 116M Dec/2025
Enanta Pharmaceuticals USD -23.54M 6.31M Dec/2024
Grifols EUR 320.55M 91.01M Dec/2025
Immunic USD -23.33M 2.67M Dec/2025
Insmed USD -101.31M 98.97M Jun/2026
Omeros USD -48.15M 7.25M Sep/2023
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD -15.3M 12.1M Jun/2026
Ultragenyx Pharmaceutical USD -75M 141M Jun/2026
United Therapeutics USD 375.6M 49.8M Jun/2026